Diagnostic Yield of Genome Sequencing Versus Exome Sequencing in Pediatric Patients With Rare Phenotypes: A Systematic Review and Meta‐Analysis
American Journal of Medical Genetics Part A · 2025-10 · 197 (10)
DOI: 10.1002/ajmg.a.64146 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift American Journal of Medical Genetics Part A, online erschienen am 16.06.2025. Verfasst von Anna Luiza Braga Albuquerque und 7 weiteren Autor:innen. Beteiligte Einrichtung: Federal University of Minas Gerais, Belo Horizonte, Brazil. Hauptthemen laut MEDLINE: Exome Sequencing, Rare Diseases, Whole Genome Sequencing, Exome. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Rare diseases affect 6% of Western societies and are a leading cause of pediatric mortality. The popularization of Next Generation Sequencing technologies, especially exome sequencing (ES), revolutionized the diagnosis of children with rare disease. Still, most patients face extensive diagnostic odysseys and remain undiagnosed. Recently, genome sequencing (GS) emerged in hope that its broader coverage could improve diagnostic yield compared to ES. This study aims to systematically review and meta‐analyze the diagnostic power of ES versus GS in pediatric populations with rare diseases. A systematic review of PubMed, Cochrane, and Embase databases was performed on December 11, 2024, for nonrandomized studies comparing GS diagnostic yield with ES or ES reanalysis in pediatric populations with rare disease. Statistical analyses were performed in R software version 4.4.2, and the study was registered on PROSPERO (CRD42024619640). In a cohort of 1684 patients from 11 studies, GS‐specific diagnostic yield was 7.0% (95% CI: 5.1%–9.5%; p < 0.0001). Subgroup analysis revealed that ES reanalysis and GS provided statistically similar diagnostic yields in patients with prior negative ES due to overlapping confidence intervals. The diagnostic rate of ES reanalysis was 14.2% (8.9%–21.8%; p < 0.0001), while total GS diagnostic yield in the same cohort was 24.1% (17.6%–31.9%; p < 0.0239). This meta‐analysis showed that GS could establish molecular diagnoses in 7.0% more patients after negative ES. However, similar diagnostic yields from ES reanalysis and GS emphasize the importance of periodic reanalysis and variant reinterpretation in diagnostic workflows.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Federal University of Minas Gerais, Belo Horizonte, Brazil.
- Faculty of Medicine of ABC, Santo André, Brazil.
- Hospital Universitari Joan XXIII, Tarragona, Spain.
- Franciscan University, Santa Maria, Brazil.
- Federal University of Amazonas, Manaus, Brazil.
- State University of Minas Gerais, Passos, Brazil.
ORCID-Profile: Anna Luiza Braga Albuquerque
Zitieren
APA
Albuquerque, A. L. B., Dos Santos, G. G., Sadok, S. H., Antonello, B. B., de Jesus, L. M., de Carvalho, M. E. A., Mutarelli, A., & Ribeiro, P. V. Z. (2025). Diagnostic Yield of Genome Sequencing Versus Exome Sequencing in Pediatric Patients With Rare Phenotypes: A Systematic Review and Meta‐Analysis. American Journal of Medical Genetics Part A, 197(10). https://doi.org/10.1002/ajmg.a.64146
Vancouver
Albuquerque ALB, Dos Santos GG, Sadok SH, Antonello BB, de Jesus LM, de Carvalho MEA, et al. Diagnostic Yield of Genome Sequencing Versus Exome Sequencing in Pediatric Patients With Rare Phenotypes: A Systematic Review and Meta‐Analysis. American Journal of Medical Genetics Part A. 2025;197(10). doi:10.1002/ajmg.a.64146
BibTeX
@article{Albuquerque2025,
author = {Albuquerque, Anna Luiza Braga and Dos Santos, Giovanna Giovacchini and Sadok, Sara Hadj and Antonello, Breno Bopp and de Jesus, Lorena Melo and de Carvalho, Maria Eduarda Andrade and Mutarelli, Antonio and Ribeiro, Paulo Victor Zattar},
title = {Diagnostic Yield of Genome Sequencing Versus Exome Sequencing in Pediatric Patients With Rare Phenotypes: A Systematic Review and Meta‐Analysis},
journal = {American Journal of Medical Genetics Part A},
year = {2025},
volume = {197},
number = {10},
doi = {10.1002/ajmg.a.64146}
}
EUVIMED